US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 13.180
  • -0.380-2.80%
Close Mar 28 16:00 ET
  • 13.140
  • -0.040-0.30%
Post 18:36 ET
1.13BMarket Cap-3.54P/E (TTM)

Syndax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-71.17%-274.9M
-38.79%-57.39M
-39.57%-62.32M
-102.55%-71.65M
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
Net income from continuing operations
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
Depreciation and amortization
-33.33%8K
--0
-33.33%2K
0.00%3K
0.00%3K
-63.64%12K
0.00%3K
-62.50%3K
-72.73%3K
-72.73%3K
Other non cash items
37.89%1.02M
-2.06%238K
24.47%295K
62.42%242K
121.82%244K
-51.51%739K
116.96%243K
-73.43%237K
-42.25%149K
-58.02%110K
Change In working capital
-58.35%13.27M
4.52%27.19M
693.90%12.63M
-312.31%-10.07M
-3,289.51%-16.47M
1,823.91%31.86M
86.20%26.01M
-39.60%1.59M
171.10%4.75M
94.13%-486K
-Change in receivables
---11.24M
-8,729.41%-6M
317.44%8.48M
-292.54%-7.64M
---6.07M
--0
-101.50%-68K
-145.53%-3.9M
157.98%3.97M
--0
-Change in inventory
---366K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
-1,341.57%-8.39M
-19.79%3.17M
-185.48%-10.68M
180.49%1.96M
-198.45%-2.85M
122.75%676K
-15.84%3.96M
-36.30%-3.74M
-169.69%-2.44M
134.39%2.9M
-Change in payables and accrued expense
1.59%20.8M
61.04%18.38M
55.66%14.37M
-177.08%-4.09M
-43.79%-7.86M
152.75%20.48M
39.17%11.42M
389.80%9.23M
259.02%5.3M
-185.18%-5.47M
-Change in other current assets
--463K
--0
----
----
----
--0
--0
----
----
----
-Change in other working capital
12.08%12M
----
----
----
-84.87%315K
408.18%10.71M
----
----
----
--2.08M
Cash from discontinued investing activities
Operating cash flow
-71.17%-274.9M
-38.79%-57.39M
-39.57%-62.32M
-102.55%-71.65M
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
Investing cash flow
Cash flow from continuing investing activities
-286.87%-219.78M
-1,551.15%-268.97M
116.70%86.85M
-16.45%61.75M
-599.12%-99.4M
163.17%117.61M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.92M
Net PPE purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-286.87%-219.78M
-1,551.15%-268.97M
116.70%86.85M
-16.45%61.75M
-599.12%-99.4M
163.09%117.61M
88.16%-16.29M
671.06%40.08M
247.97%73.91M
143.40%19.92M
Cash from discontinued investing activities
Investing cash flow
-286.87%-219.78M
-1,551.15%-268.97M
116.70%86.85M
-16.45%61.75M
-599.12%-99.4M
163.17%117.61M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.92M
Financing cash flow
Cash flow from continuing financing activities
33.78%353.37M
34.41%347.43M
67.37%3.1M
-48.94%676K
-12.37%2.17M
53.34%264.13M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--0
----
----
----
----
42.29%258.09M
----
----
----
----
Proceeds from stock option exercised by employees
60.90%9.72M
869.92%3.77M
67.37%3.1M
-48.94%676K
-12.37%2.17M
-49.09%6.04M
-74.69%389K
-75.23%1.85M
-42.26%1.32M
344.17%2.47M
Net other financing activities
--343.65M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
33.78%353.37M
34.41%347.43M
67.37%3.1M
-48.94%676K
-12.37%2.17M
53.34%264.13M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
Net cash flow
Beginning cash position
296.95%295.61M
40.59%133.24M
8.33%105.61M
99.25%114.83M
296.95%295.61M
-66.47%74.47M
32.56%94.77M
-19.00%97.49M
-69.49%57.63M
-66.47%74.47M
Current changes in cash
-163.90%-141.31M
-89.51%21.06M
1,113.69%27.62M
-123.13%-9.22M
-973.57%-180.78M
249.81%221.14M
6,641.99%200.84M
94.42%-2.73M
158.16%39.86M
49.27%-16.84M
End cash Position
-47.80%154.3M
-47.80%154.3M
40.59%133.24M
8.33%105.61M
99.25%114.83M
296.95%295.61M
296.95%295.61M
32.56%94.77M
-19.00%97.49M
-69.49%57.63M
Free cash flow
-71.17%-274.9M
-38.79%-57.39M
-39.57%-62.32M
-102.55%-71.65M
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -71.17%-274.9M-38.79%-57.39M-39.57%-62.32M-102.55%-71.65M-112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M
Net income from continuing operations -52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M
Depreciation and amortization -33.33%8K--0-33.33%2K0.00%3K0.00%3K-63.64%12K0.00%3K-62.50%3K-72.73%3K-72.73%3K
Other non cash items 37.89%1.02M-2.06%238K24.47%295K62.42%242K121.82%244K-51.51%739K116.96%243K-73.43%237K-42.25%149K-58.02%110K
Change In working capital -58.35%13.27M4.52%27.19M693.90%12.63M-312.31%-10.07M-3,289.51%-16.47M1,823.91%31.86M86.20%26.01M-39.60%1.59M171.10%4.75M94.13%-486K
-Change in receivables ---11.24M-8,729.41%-6M317.44%8.48M-292.54%-7.64M---6.07M--0-101.50%-68K-145.53%-3.9M157.98%3.97M--0
-Change in inventory ---366K------------------0----------------
-Change in prepaid assets -1,341.57%-8.39M-19.79%3.17M-185.48%-10.68M180.49%1.96M-198.45%-2.85M122.75%676K-15.84%3.96M-36.30%-3.74M-169.69%-2.44M134.39%2.9M
-Change in payables and accrued expense 1.59%20.8M61.04%18.38M55.66%14.37M-177.08%-4.09M-43.79%-7.86M152.75%20.48M39.17%11.42M389.80%9.23M259.02%5.3M-185.18%-5.47M
-Change in other current assets --463K--0--------------0--0------------
-Change in other working capital 12.08%12M-------------84.87%315K408.18%10.71M--------------2.08M
Cash from discontinued investing activities
Operating cash flow -71.17%-274.9M-38.79%-57.39M-39.57%-62.32M-102.55%-71.65M-112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M
Investing cash flow
Cash flow from continuing investing activities -286.87%-219.78M-1,551.15%-268.97M116.70%86.85M-16.45%61.75M-599.12%-99.4M163.17%117.61M88.16%-16.29M689.97%40.08M247.97%73.91M143.40%19.92M
Net PPE purchase and sale --0------------------0----------------
Net investment purchase and sale -286.87%-219.78M-1,551.15%-268.97M116.70%86.85M-16.45%61.75M-599.12%-99.4M163.09%117.61M88.16%-16.29M671.06%40.08M247.97%73.91M143.40%19.92M
Cash from discontinued investing activities
Investing cash flow -286.87%-219.78M-1,551.15%-268.97M116.70%86.85M-16.45%61.75M-599.12%-99.4M163.17%117.61M88.16%-16.29M689.97%40.08M247.97%73.91M143.40%19.92M
Financing cash flow
Cash flow from continuing financing activities 33.78%353.37M34.41%347.43M67.37%3.1M-48.94%676K-12.37%2.17M53.34%264.13M58.09%258.48M113.69%1.85M-93.90%1.32M344.17%2.47M
Net issuance payments of debt --0------------------0----------------
Net common stock issuance --0----------------42.29%258.09M----------------
Proceeds from stock option exercised by employees 60.90%9.72M869.92%3.77M67.37%3.1M-48.94%676K-12.37%2.17M-49.09%6.04M-74.69%389K-75.23%1.85M-42.26%1.32M344.17%2.47M
Net other financing activities --343.65M------------------------------------
Cash from discontinued financing activities
Financing cash flow 33.78%353.37M34.41%347.43M67.37%3.1M-48.94%676K-12.37%2.17M53.34%264.13M58.09%258.48M113.69%1.85M-93.90%1.32M344.17%2.47M
Net cash flow
Beginning cash position 296.95%295.61M40.59%133.24M8.33%105.61M99.25%114.83M296.95%295.61M-66.47%74.47M32.56%94.77M-19.00%97.49M-69.49%57.63M-66.47%74.47M
Current changes in cash -163.90%-141.31M-89.51%21.06M1,113.69%27.62M-123.13%-9.22M-973.57%-180.78M249.81%221.14M6,641.99%200.84M94.42%-2.73M158.16%39.86M49.27%-16.84M
End cash Position -47.80%154.3M-47.80%154.3M40.59%133.24M8.33%105.61M99.25%114.83M296.95%295.61M296.95%295.61M32.56%94.77M-19.00%97.49M-69.49%57.63M
Free cash flow -71.17%-274.9M-38.79%-57.39M-39.57%-62.32M-102.55%-71.65M-112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More